AUG 17, 2016 7:15 PM PDT

Redefining A Cell's Identity with Gene Editing

WRITTEN BY: Kara Marker
Just a couple of miles down the road from North Carolina State University where CRISPR pioneer Rodolphe Barrangou, PhD, has his lab, scientists at Duke University are modifying the genetic modifying technique to directly activate existing gene copies in the genome rather than adding additional copies. The result? A complete reprogramming of a cell’s identity.
Charles Gersbach, director for the Center of Biomolecular and Tissue Engineering at Duke University
In the past, scientists have used viruses, injected into the genome, to introduce extra copies of certain genes to produce a large number of “master transcription factors” in order to induce a permanent change in the cell’s gene network. However, after realizing that a temporary signal that could change the cell type to reach a stable destination would be more effective than making irreversible changes, the research group from Duke decided to tweak current CRISPR technology to create a temporary signal.

In their study, the researchers used a “splice-less” version of CRISPR to identify specific regions of DNA and attach them to a gene activator to activate exactly three genes. (For more about CRISPR gene editing technology, click here.) The three genes they activated naturally produce the master transcription factors in the cell’s genome responsible for controlling the neuronal gene network. Activating the network in this manner created newly-converted neuronal cells with a more complete and persistent conversion profile than with techniques using viruses.

Using this version of CRISPR technology to convert isolated mouse connective tissue cells directly into neuronal cells could be applied to modeling neurological disorders, discovering new therapeutics, developing personalized medicines, and even implementing cell therapy, researchers report. Duke scientist Charles Gersbach provides an example: 

“We might have a general idea of how most people's neurons will respond to a drug, but we don't know how your particular neurons with your particular genetics will respond. If we could take a skin cell from your arm, turn it into a neuron, and then treat it with various drug combinations, we could determine an optimal personalized therapy."

The experimental method in this study pose a challenge to scientists: producing stable neuronal cells efficiently while also ensuring their genome looks like a “real” neuron. In the future, Duke scientists plan to apply this technology to isolated human cells as well as improve the technique’s efficiency and apply it to model particular diseases.

This study was recently published in the journal Cell Stem Cell.
 


Source: Duke University
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
DEC 29, 2019
Cell & Molecular Biology
DEC 29, 2019
A Molecular Switch for Modulating Gene Therapy Doses
  Genetic errors cause many different kinds of diseases, and gene therapy has aimed to relieve those symptoms by addressing the root cause....
JAN 14, 2020
Genetics & Genomics
JAN 14, 2020
Genetic Study Reveals Drug Targets for Several Diseases
Some genetic mutations are due to a change in only one base of the genetic code, while others involve large regions of the genome....
JAN 20, 2020
Genetics & Genomics
JAN 20, 2020
Epigenetic Changes Make Breast Cancer Cells Drug Resistant
Researchers have found that changes in the structure of the genome in breast cancer cells can make them resistant to drug therapies....
JAN 28, 2020
Genetics & Genomics
JAN 28, 2020
Developing a Gene Therapy to Treat Duchenne Muscular Dystrophy
Because of a genetic mutation, people that have Duchenne muscular dystrophy lack functional copies of a protein called dystrophin....
FEB 10, 2020
Genetics & Genomics
FEB 10, 2020
The Broken Genes of the Last Woolly Mammoths
Wooly mammoths are thought to have died out around 4,000 years ago in a remote area off the Siberian coast, called Wrangel Island....
FEB 11, 2020
Neuroscience
FEB 11, 2020
Soybean oil Causes Genetic Changes in Mouse Brain
Source: Hypothalmus and limic system   Soybean oil is used for cooking fast food, in packaged products, and to feed livestock, making it the most wide...
Loading Comments...